Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Por Rubin, C M, Carrino, J J, Dickler, M N, Leibowitz, D, Smith, S D, Westbrook, C A
Publicado em 1988

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Por Yang, C, Li, Z, Bhatt, T, Dickler, M, Giri, D, Scaltriti, M, Baselga, J, Rosen, N, Chandarlapaty, S
Publicado no Oncogene (2017)

A deletion/insertion polymorphism in the human BCR gene on chromosome 22.

Por Rubin, C M, Blazar, B R, Hooberman, A L, Dickler, M N, Miller, B A, Westbrook, C A
Publicado em 1988

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Por Fornier, M. N., Morris, P. G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A. D., Sklarin, N., Chang, J., Norton, L., Hudis, C. A.
Publicado no Ann Oncol (2011)

Oncologist use and perception of large panel next-generation tumor sequencing

Por Schram, A. M., Reales, D., Galle, J., Cambria, R., Durany, R., Feldman, D., Sherman, E., Rosenberg, J., D’Andrea, G., Baxi, S., Janjigian, Y., Tap, W., Dickler, M., Baselga, J., Taylor, B. S., Chakravarty, D., Gao, J., Schultz, N., Solit, D. B., Berger, M. F., Hyman, D. M.
Publicado no Ann Oncol (2017)